Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-06-16 Vaish Renu V.P., Global Reg. Affairs Exercise or conversion · Stock Option (right To Purchase) −5,000 115,605
2016-03-11 HEALY JAMES Director Purchase +541,343 $7.30 $4.0M 2,852,711
2016-03-11 LOUGHLIN JAMES J Director Purchase +100 $7.58 $758 100
2016-03-11 LOUGHLIN JAMES J Director Purchase +13 $7.63 $99 113
2016-03-11 LOUGHLIN JAMES J Director Purchase +500 $7.64 $4K 613
2016-03-11 LOUGHLIN JAMES J Director Purchase +1,107 $7.64 $8K 1,720
2016-03-11 LOUGHLIN JAMES J Director Purchase +600 $7.64 $5K 2,320
2016-03-11 LOUGHLIN JAMES J Director Purchase +500 $7.63 $4K 2,820
2016-03-11 LOUGHLIN JAMES J Director Purchase +180 $7.63 $1K 3,000
2016-03-01 Faleck Herbert J Chief Medical Officer Grant or award · Stock Option (right To Purchase) +25,000 25,000
2016-02-16 MARCHIO ALBERT N II Chief Accounting & Ops Officer Grant or award · Stock Option (Right to Purchase) +35,000 35,000
2016-02-16 Macdonald R. Loch Chief Scientific Officer Grant or award · Stock Option (Right to Purchase) +85,000 85,000
2016-02-16 Vaish Renu V.P., Global Reg. Affairs Grant or award · Stock Option (Right to Purchase) +30,500 30,500
2016-02-16 Leuthner Brian A President and CEO Grant or award · Stock Option (Right to Purchase) +230,000 230,000
2016-02-16 Einhorn Andrew J. Chief Financial Officer Grant or award · Stock Option (Right to Purchase) +50,000 50,000
2016-02-16 Yaman Alpaslan V.P., Technical Ops. & Mfg. Grant or award · Stock Option (Right to Purchase) +35,000 35,000
2016-02-16 MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary Grant or award · Stock Option (Right to Purchase) +35,000 35,000
2016-02-16 Faleck Herbert J Chief Medical Officer Grant or award · Stock Option (Right to Purchase) +110,000 110,000
2015-11-16 MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary Grant or award · Stock Option (Right to Purchase) +80,000 80,000
2015-10-06 Conti Kurt G Director Conversion +160,810 160,810

Page 14 of 18 · 346 trades